Sara H Ksiazek, Martin Windpessl, Emanuel Zitt, Michael Rudnicki, Kathrin Eller, Christoph Schwarz, Marlies Antlanger, Sabine Schmaldienst, Daniel Cejka, Rainer Oberbauer, Alexander R Rosenkranz, Marcus D Säemann
{"title":"[Recommendations for the Diagnosis and Treatment of Chronic Kidney Disease (CKD) by the Austrian Society of Nephrology].","authors":"Sara H Ksiazek, Martin Windpessl, Emanuel Zitt, Michael Rudnicki, Kathrin Eller, Christoph Schwarz, Marlies Antlanger, Sabine Schmaldienst, Daniel Cejka, Rainer Oberbauer, Alexander R Rosenkranz, Marcus D Säemann","doi":"10.1007/s00508-025-02590-y","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic kidney disease (CKD) affects over 800 million people worldwide, yet only about 6-10% of those affected are aware of their condition. Limited public awareness and insufficient structural measures in the healthcare system lead to the fact that CKD is frequently not diagnosed or diagnosed after a delay and therefore insufficiently treated. Current projections estimate that CKD could become the fifth leading cause of death worldwide by 2040, if timely and effective measures to increase awareness and early detection are not implemented. This article presents practice-oriented guidelines for the screening, diagnostics and treatment of CKD in Austria. It outlines for which risk groups screening is recommended and describes how physicians can diagnose and treat CKD across all medical specialties. A key aspect of these guidelines is the presentation of pharmacological treatment options that slow disease progression, with specific indications and practical clinical recommendations for their use. Furthermore, the recommendations address nationally defined referral criteria to nephrology specialists in Austria and discusses possible CKD-related complications along with appropriate treatment strategies.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":"137 Suppl 8","pages":"243-258"},"PeriodicalIF":2.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479600/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener Klinische Wochenschrift","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00508-025-02590-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic kidney disease (CKD) affects over 800 million people worldwide, yet only about 6-10% of those affected are aware of their condition. Limited public awareness and insufficient structural measures in the healthcare system lead to the fact that CKD is frequently not diagnosed or diagnosed after a delay and therefore insufficiently treated. Current projections estimate that CKD could become the fifth leading cause of death worldwide by 2040, if timely and effective measures to increase awareness and early detection are not implemented. This article presents practice-oriented guidelines for the screening, diagnostics and treatment of CKD in Austria. It outlines for which risk groups screening is recommended and describes how physicians can diagnose and treat CKD across all medical specialties. A key aspect of these guidelines is the presentation of pharmacological treatment options that slow disease progression, with specific indications and practical clinical recommendations for their use. Furthermore, the recommendations address nationally defined referral criteria to nephrology specialists in Austria and discusses possible CKD-related complications along with appropriate treatment strategies.
期刊介绍:
The Wiener klinische Wochenschrift - The Central European Journal of Medicine - is an international scientific medical journal covering the entire spectrum of clinical medicine and related areas such as ethics in medicine, public health and the history of medicine. In addition to original articles, the Journal features editorials and leading articles on newly emerging topics, review articles, case reports and a broad range of special articles. Experimental material will be considered for publication if it is directly relevant to clinical medicine. The number of international contributions has been steadily increasing. Consequently, the international reputation of the journal has grown in the past several years. Founded in 1888, the Wiener klinische Wochenschrift - The Central European Journal of Medicine - is certainly one of the most prestigious medical journals in the world and takes pride in having been the first publisher of landmarks in medicine.